share_log

Virios Therapeutics | 8-K: Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

SEC ·  Feb 29 22:28
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.